Skip to main content

Table 5 Comparison between patients administered different drugs for MS regarding BDNF level

From: Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity

Drugs BDNF level (pg/ml) (remission group) BDNF level (pg/ml) (relapse group)
Median Q1 Q3 P value Median Q1 Q3 P value
Monthly methylprednisolone 220 175 245 0.617 325 255 950 0.792
Intramuscular Interferon beta-1a 275 205 325 250 250 250
Subcutaneous Interferon beta-1b 265 205 325 268 245 1500
Subcutaneous interferon beta-1a 223 213 2613 2608 215 5000
  1. BDNF brain-derived neurotrophic factor